{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:40:12Z","timestamp":1771000812576,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.vaccine.2009.08.029","type":"journal-article","created":{"date-parts":[[2009,8,27]],"date-time":"2009-08-27T08:41:34Z","timestamp":1251362494000},"page":"6129-6136","source":"Crossref","is-referenced-by-count":28,"title":["Immune response and prophylactic efficacy of smegmosomes in a hamster model of leptospirosis"],"prefix":"10.1016","volume":"27","author":[{"given":"Syed M.","family":"Faisal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WeiWei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean P.","family":"McDonough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussni O.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Divers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Fu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.vaccine.2009.08.029_bib1","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1086\/339942","article-title":"Leptospirosis, water sports, and chemoprophylaxis","volume":"34","author":"Haake","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2009.08.029_bib2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3201\/eid1003.030431","article-title":"Reemerging leptospirosis California","volume":"10","author":"Meites","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2009.08.029_bib3","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1086\/340615","article-title":"Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998","volume":"34","author":"Morgan","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.029_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11908-006-0035-3","article-title":"Leptospirosis in the tropics and in travelers","volume":"8","author":"Ricaldi","year":"2006","journal-title":"Curr Infect Dis Rep"},{"issue":"6","key":"10.1016\/j.vaccine.2009.08.029_bib5","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3201\/eid0906.020751","article-title":"Leptospirosis in \u201cEco-Challenge\u201d athletes, Malaysian Borneo, 2000","volume":"9","author":"Sejvar","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2009.08.029_bib6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/01.qco.0000178824.05715.2c","article-title":"Leptospirosis","volume":"18","author":"McBride","year":"2005","journal-title":"Curr Opin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2009.08.029_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/vr.153.6.165","article-title":"Comparison of the efficacy of three commercial bacterins in preventing canine leptospirosis","volume":"153","author":"Andre-Fontaine","year":"2003","journal-title":"Vet Rec"},{"issue":"12","key":"10.1016\/j.vaccine.2009.08.029_bib8","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1473-3099(03)00830-2","article-title":"Leptospirosis: a zoonotic disease of global importance","volume":"3","author":"Bharti","year":"2003","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.029_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2460\/ajvr.1989.50.01.161","article-title":"Effect of vaccination with a pentavalent leptospiral vaccine on Leptospira interrogans serovar Hardjo type hardjo-bovis infection of pregnant cattle","volume":"50","author":"Bolin","year":"1989","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2009.08.029_bib10","unstructured":"Faine SB, Adher B, Bolin C, Perolat P, editors. Leptospira and Leptospirosis. Medbourne, Australia: Med Sci, 1999."},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.029_bib11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1128\/CMR.14.2.296-326.2001","article-title":"Leptospirosis","volume":"14","author":"Levett","year":"2001","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.029_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0264-410X(00)00129-8","article-title":"Evidence of cross-protection within Leptospira interrogans in an experimental model","volume":"19","author":"Sonrier","year":"2000","journal-title":"Vaccine"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2009.08.029_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0165-2427(02)00091-0","article-title":"Activation of bovine peripheral blood gammadelta T cells for cell division and IFN-gamma production","volume":"87","author":"Baldwin","year":"2002","journal-title":"Vet Immunol Immunopathol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.08.029_bib14","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.4049\/jimmunol.171.3.1447","article-title":"Leptospira interrogans activation of human peripheral blood mononuclear cells: preferential expansion of TCR gamma delta+ T cells vs TCR alpha beta+ T cells","volume":"171","author":"Klimpel","year":"2003","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.08.029_bib15","doi-asserted-by":"crossref","first-page":"7550","DOI":"10.1128\/IAI.69.12.7550-7558.2001","article-title":"Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and gammadelta T lymphocytes","volume":"69","author":"Naiman","year":"2001","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2009.08.029_bib16","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1128\/IAI.70.11.6147-6157.2002","article-title":"Evaluation of type 1 immune response in naive and vaccinated animals following challenge with Leptospira borgpetersenii serovar Hardjo: involvement of WC1(+) gammadelta and CD4 T cells","volume":"70","author":"Naiman","year":"2002","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2009.08.029_bib17","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0958-1669(05)80126-0","article-title":"Recombinant subunit vaccines","volume":"2","author":"Burnette","year":"1991","journal-title":"Curr Opin Biotechnol"},{"issue":"48","key":"10.1016\/j.vaccine.2009.08.029_bib18","doi-asserted-by":"crossref","first-page":"8190","DOI":"10.1016\/j.vaccine.2007.09.020","article-title":"Immunogenicity of the recombinant leptospiral putative outer membrane proteins as vaccine candidates","volume":"25","author":"Chang","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.029_bib19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.vaccine.2008.10.089","article-title":"Variable region of Leptospira immunoglobulin like protein A (LigAvar) incorporated in Liposomes and PLGA-Microspheres produces a robust immune response correlating to protective immunity against challenge in hamsters","volume":"27","author":"Faisal","year":"2009","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2009.08.029_bib20","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.1128\/IAI.67.12.6572-6582.1999","article-title":"Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection","volume":"67","author":"Haake","year":"1999","journal-title":"Infect Immun"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2009.08.029_bib21","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.vaccine.2003.10.007","article-title":"Leptospiral immunoglobulin-like proteins elicit protective immunity","volume":"22","author":"Koizumi","year":"2004","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.08.029_bib22","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1128\/IAI.74.3.1745-1750.2006","article-title":"Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection","volume":"74","author":"Palaniappan","year":"2006","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.029_bib23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.vaccine.2007.10.052","article-title":"Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge","volume":"26","author":"Seixas","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.029_bib24","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1016\/j.vaccine.2007.05.053","article-title":"The terminal portion of leptospiral immunoglobulin-like protien A confers protective immunity against lethal infection in the hamster model of leptospirosis","volume":"25","author":"Silva","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.029_bib25","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.micinf.2008.11.008","article-title":"Immunogenicity and protective efficacy of recombinant Leptospira immunoglobulin-like protein B (rLigB) in a hamster challenge model","volume":"11","author":"Yan","year":"2009","journal-title":"Microb Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2009.08.029_bib26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0169-409X(98)00008-8","article-title":"Aluminum compounds as vaccine adjuvants","volume":"32","author":"Gupta","year":"1998","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2009.08.029_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0264-410X(93)90190-9","article-title":"Adjuvants\u2013a balance between toxicity and adjuvanticity","volume":"11","author":"Gupta","year":"1993","journal-title":"Vaccine"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2009.08.029_bib28","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0264-410X(97)00288-0","article-title":"Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids","volume":"16","author":"Relyveld","year":"1998","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2009.08.029_bib29","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1128\/IAI.72.9.5235-5246.2004","article-title":"Activation of dendritic cells by liposomes prepared from phosphatidylinositol mannosides from Mycobacterium bovis bacillus Calmette-Guerin and adjuvant activity in vivo","volume":"72","author":"Sprott","year":"2004","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2009.08.029_bib30","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1128\/IAI.73.9.5817-5826.2005","article-title":"Cationic liposomes containing mycobacterial lipids: a new powerful Th1 adjuvant system","volume":"73","author":"Rosenkrands","year":"2005","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.029_bib31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.vaccine.2007.10.029","article-title":"Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters","volume":"26","author":"Faisal","year":"2008","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2009.08.029_bib32","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can J Biochem Physiol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.029_bib33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/02652048409031535","article-title":"Preparation of liposomes containing factor VIII for oral treatment of haemophilia","volume":"1","author":"Kirby","year":"1984","journal-title":"J Microencapsul"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2009.08.029_bib34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0304-4157(92)90004-T","article-title":"Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigens","volume":"1113","author":"Alving","year":"1992","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"10.1016\/j.vaccine.2009.08.029_bib35","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0264-410X(91)90295-H","article-title":"Controlled release microparticles for vaccine development","volume":"9","author":"O\u2019Hagan","year":"1991","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.029_bib36","first-page":"239","article-title":"Biodegradable microparticles as controlled release antigen delivery systems","volume":"73","author":"O\u2019Hagan","year":"1991","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.vaccine.2009.08.029_bib37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0167-5699(90)90034-7","article-title":"Immunological adjuvants: a role for liposomes","volume":"11","author":"Gregoriadis","year":"1990","journal-title":"Immunol Today"},{"issue":"7","key":"10.1016\/j.vaccine.2009.08.029_bib38","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/10611860802228558","article-title":"Liposomes act as stronger sub-unit vaccine adjuvants when compared to microspheres","volume":"16","author":"Kirby","year":"2008","journal-title":"J Drug Target"},{"issue":"7","key":"10.1016\/j.vaccine.2009.08.029_bib39","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1080\/10611860802228376","article-title":"Gregory Gregoriadis: Introducing liposomes to drug delivery","volume":"16","author":"Perrie","year":"2008","journal-title":"J Drug Target"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.029_bib40","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpharm.2008.04.036","article-title":"Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens","volume":"364","author":"Perrie","year":"2008","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.vaccine.2009.08.029_bib41","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1016104910582","article-title":"Recent advances in vaccine adjuvants","volume":"19","author":"Singh","year":"2002","journal-title":"Pharm Res"},{"issue":"8","key":"10.1016\/j.vaccine.2009.08.029_bib42","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1586\/14760584.7.8.1141","article-title":"Epaxal: a virosomal vaccine to prevent hepatitis A infection","volume":"7","author":"Bovier","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.08.029_bib43","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbamem.2005.10.011","article-title":"Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6\u2032-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses","volume":"1718","author":"Davidsen","year":"2005","journal-title":"Biochim Biophys Acta"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2009.08.029_bib44","first-page":"2383","article-title":"Antigen entrapped in the escheriosomes leads to the generation of CD4(+) helper and CD8(+) cytotoxic T cell response","volume":"21","author":"Faisal","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.029_bib45","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1128\/IAI.68.1.54-63.2000","article-title":"Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum","volume":"68","author":"Krishnan","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.029_bib46","first-page":"130","article-title":"The mode of action of immunologic adjuvants","volume":"10","author":"Fruend","year":"1956","journal-title":"Bibl Tuberc"},{"issue":"3","key":"10.1016\/j.vaccine.2009.08.029_bib47","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1128\/IAI.72.3.1608-1617.2004","article-title":"Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines","volume":"72","author":"Holten-Andersen","year":"2004","journal-title":"Infect Immun"},{"issue":"20","key":"10.1016\/j.vaccine.2009.08.029_bib48","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/S0264-410X(98)00084-X","article-title":"Enhancing activity of mycobacterial cell-derived adjuvants on immunogenicity of recombinant human hepatitis B virus vaccine","volume":"16","author":"Koike","year":"1998","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2009.08.029_bib49","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0264-410X(97)00268-5","article-title":"Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers","volume":"16","author":"McBride","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.029_bib50","series-title":"Antigens. Lymphoid cells and the immune response","author":"Nossal","year":"1971"},{"key":"10.1016\/j.vaccine.2009.08.029_bib51","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1600-065X.1997.tb00969.x","article-title":"Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity","volume":"156","author":"Zinkernagel","year":"1997","journal-title":"Immunol Rev"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2009.08.029_bib52","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.vaccine.2003.11.054","article-title":"Liposome adjuvants prepared from the total polar lipids of Haloferax volcanii. Planococcus spp. and Bacillus firmus differ in ability to elicit and sustain immune responses","volume":"22","author":"Sprott","year":"2004","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09012055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09012055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T21:53:40Z","timestamp":1739310820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09012055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":52,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0264410X09012055"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.08.029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}